Suspended NCT03513549
This summary needs review. Please check the official study record and contact the research team for details.
In Raleigh Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Schizophrenia Drug i A study involving a medication or substance. Over 18 Years
Countries United States
Sponsor Alexza Pharmaceuticals, Inc.
Condition Bipolarity, Schizophrenia Completed NCT03953417
This summary needs review. Please check the official study record and contact the research team for details.
In Palo Alto Why is this study shown? This study includes Bipolarity among several conditions.
Depression, Bipolarity Device i A study involving a tool, app, wearable, test, or medical device. From 18 Years to 80 Years
Countries United States
Sponsor Stanford University
Condition Depression, Bipolarity Completed NCT01527448
This summary needs review. Please check the official study record and contact the research team for details.
In Vancouver Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Drug From 19 Years to 40 Years
Countries Canada
Sponsor BC Women's Hospital & Health Centre
Condition Bipolarity, Depression Completed NCT00436020
This summary needs review. Please check the official study record and contact the research team for details.
In Prahran Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Device From 18 Years to 70 Years
Countries Australia
Sponsor Bayside Health
Condition Bipolarity, Depression Completed NCT01093937
This summary needs review. Please check the official study record and contact the research team for details.
In Toronto Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Addiction Drug From 18 Years to 65 Years
Countries Canada
Sponsor Centre for Addiction and Mental Health
Condition Bipolarity, Addiction Completed NCT01305408
This study is completed in the United States, in Argentina, in Brazil, .... It is testing Armodafinil Treatment (150 mg/Day) for depression.
Multiple locations, including Birmingham Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Drug From 18 Years to 65 Years
Countries United States, Argentina, Brazil, ...
Sponsor Cephalon
Condition Bipolarity, Depression Completed NCT01072630
This study is completed in the United States, in Australia, in France, .... It is testing armodafinil Treatment for depression.
Multiple locations, including Birmingham Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Drug From 18 Years to 65 Years
Countries United States, Australia, France, ...
Sponsor Cephalon
Condition Bipolarity, Depression Completed NCT03287037
This summary needs review. Please check the official study record and contact the research team for details.
In Taipei Why is this study shown? This study includes Bipolarity among several conditions.
Depression, Bipolarity Behavioral From 20 Years to 65 Years
Countries Taiwan
Sponsor Tri-Service General Hospital (TSGH)
Condition Depression, Bipolarity Completed NCT00186758
This summary needs review. Please check the official study record and contact the research team for details.
In Hamilton Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Device From 18 Years to 65 Years
Countries Canada
Sponsor St. Joseph's Healthcare Hamilton
Condition Bipolarity, Depression Not recruiting ISRCTN83333181
This study is not recruiting in Colombia. It focuses on Bipolarity.
In Colombia Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Schizophrenia, ... Other From 18 Years to 65 Years
Countries Colombia
Sponsor Queen Mary University of London
Condition Bipolarity, Schizophrenia, ... Not recruiting ISRCTN38360953
This study is not recruiting in Peru. It focuses on Bipolarity.
In Peru Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Schizophrenia, ... Other From 18 Years to 65 Years
Countries Peru
Sponsor Queen Mary University of London
Condition Bipolarity, Schizophrenia, ... Not recruiting ISRCTN27649427
This study is looking at care and outcomes for people with Depression in bipolarity or Mental and Behavioural Disorders. Taking part may give some people access to Adjunctive treatment with mifepristone (600 mg/day for 7 days) versus placebo, but direct benefit is not guaranteed.
In United Kingdom Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Other From 18 Years to 65 Years
Countries United Kingdom
Sponsor The Newcastle, North Tyneside And Northumberland Mental Health NHS Trust (UK)
Condition Bipolarity, Depression